BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7483543)

  • 1. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders].
    Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM
    Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histoenzymological and electron microscopy changes in the gastric mucosa of patients with peptic ulcer].
    Degtiareva II; Matvienko AV
    Vrach Delo; 1985 Feb; (2):20-6. PubMed ID: 3992979
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal plasminogen activator activity in peptic ulcer disease.
    Wodzinski MA; Bardhan KD; Cooper P; Reilly JT; Preston FE
    Ann N Y Acad Sci; 1992 Dec; 667():181-2. PubMed ID: 1364068
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].
    Ionov ID
    Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphological changes in the gastric mucosa of peptic ulcer patients].
    Degtiareva II; Matvienko AV; Rodonezhskaia EV
    Vrach Delo; 1984 Nov; (11):83-8. PubMed ID: 6528567
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic treatment of ulcers].
    Honorato Pérez J; Azanza Perea JR; Cuena Boy R
    Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of H1- and H2-histamine receptor blockaders on lesions of the gastric mucosa evoked by exogenous histamine in guinea pigs].
    Karevina TG
    Patol Fiziol Eksp Ter; 1990; (5):43-5. PubMed ID: 1981390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histamine H2 receptor antagonists. Notes on clinical pharmacology].
    Pelosio L; Marasco A; Naim U
    Clin Ter; 1979 Nov; 91(4):421-7. PubMed ID: 44237
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of gastric mucosa carbonic anhydrase by pirenzepine in patients with gastroduodenal ulcers.
    Puşcaş I; Búzás G; Surányi P; Domuta M
    Arzneimittelforschung; 1981; 31(3):508-9. PubMed ID: 6894381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present status and future perspectives of muscarinic receptor antagonists.
    Londong W
    Scand J Gastroenterol Suppl; 1986; 125():55-60. PubMed ID: 2881347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Vasil'eva ZI
    Klin Med (Mosk); 1988 Nov; 66(11):19-27. PubMed ID: 2907071
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
    Mazure PA
    Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
    Ivashkin VT; Minasian GA
    Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
    [No Abstract]   [Full Text] [Related]  

  • 17. Single nocturnal doses of pirenzepine effectively inhibit overnight gastric secretion.
    Howden CW; Burget DW; Silletti C; Hunt RH
    Hepatogastroenterology; 1985 Oct; 32(5):240-2. PubMed ID: 2867023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current locally acting agents in the treatment of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1986 Aug; 64(8):18-27. PubMed ID: 2878103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gastric secretion blockaders in peptic ulcer].
    Arutionian VM; Minasian GA
    Sov Med; 1989; (7):45-8. PubMed ID: 2572058
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of ulcer healing--a new concept to rank healed peptic ulcers.
    Arakawa T; Kobayashi K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():158-62. PubMed ID: 8103020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.